A team of researchers at The Pirbright Institute have used genetic engineering to disable the chikungunya virus genome in mosquito cells. With further development, the technology could help researchers to engineer disease resistant mosquitoes, which would make them unable to spread chikungunya between animals and people.
News from September 2020
Increasing infectious bronchitis virus vaccine heat resilience could improve performance, Pirbright scientists reveal
Two recent studies from The Pirbright Institute and the University of Edinburgh’s Roslin Institute show that two vaccines against specific strains of infectious bronchitis virus (IBV) do not offer complete protection against a third strain, and that this may be partly down to the temperature range the vaccine virus can survive in.